CE
CERo Therapeutics Holdings, Inc.
CEROW · OTC
$0.00 +182.35% (+$0.00)
1M +117.65%
Market Cap $101.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A EV/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 547.09%
Asset turnover 0.00x
ROIC 388.91%
Debt
0 /100
High Current ratio 0.30x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 7,214.36%
Profitable years 0
Beta 0.16x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CEROW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Ehrlich
Employees
8
Headquarters
South San Francisco
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report